ArticleFrontiers in genetics2018
Conserved Disease Modules Extracted From Multilayer Heterogeneous Disease and Gene Networks for Understanding Disease Mechanisms and Predicting Disease Treatments.
Article in Frontiers in genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 58 citations in OpenAlex.
- Hypothesis generation for rare and undiagnosed diseases through clustering and classifying time-versioned biological ontologies.PloS one · 2024Article
- Article
- Gene communities in co-expression networks across different tissues.PLoS computational biology · 2023Article
- Network approach to understand biological systems: From single to multilayer networks.Journal of biosciences · 2022Article
- Accurate identification of RNA D modification using multiple features.RNA biology · 2021Article
- Application of machine learning in bacteriophage research.BMC microbiology · 2021Review
- Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients.Journal of gastrointestinal oncology · 2021Article
- sgRNACNN: identifying sgRNA on-target activity in four crops using ensembles of convolutional neural networks.Plant molecular biology · 2021Article
- Identification of Methicillin-Resistant Staphylococcus Aureus From Methicillin-Sensitive Staphylococcus Aureus and Molecular Characterization in Quanzhou, China.Frontiers in cell and developmental biology · 2021Article
- Application of Sparse Representation in Bioinformatics.Frontiers in genetics · 2021Review
- Predicting Preference of Transcription Factors for Methylated DNA Using Sequence Information.Molecular therapy. Nucleic acids · 2020Article
- NonClasGP-Pred: robust and efficient prediction of non-classically secreted proteins by integrating subset-specific optimal models of imbalanced data.Microbial genomics · 2020Article
- Is There Any Sequence Feature in the RNA Pseudouridine Modification Prediction Problem?Molecular therapy. Nucleic acids · 2020Article
- Identifying Antioxidant Proteins by Using Amino Acid Composition and Protein-Protein Interactions.Frontiers in cell and developmental biology · 2020Article
- Identification and Classification of Enhancers Using Dimension Reduction Technique and Recurrent Neural Network.Computational and mathematical methods in medicine · 2020Article
- A Method for Identifying Vesicle Transport Proteins Based on LibSVM and MRMD.Computational and mathematical methods in medicine · 2020Article
- Predicting Gram-Positive Bacterial Protein Subcellular Location by Using Combined Features.BioMed research international · 2020Article
- A Cancer Gene Module Mining Method Based on Bio-Network of Multi-Omics Gene Groups.Frontiers in oncology · 2020Article
- A Method for Prediction of Thermophilic Protein Based on Reduced Amino Acids and Mixed Features.Frontiers in bioengineering and biotechnology · 2020Article
- RF-PseU: A Random Forest Predictor for RNA Pseudouridine Sites.Frontiers in bioengineering and biotechnology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disease relationship studies for understanding the pathogenesis of complex diseases, diagnosis, prognosis, and drug development are important. Traditional approaches consider one type of disease data or aggregating multiple types of disease data into a single network, which results in important temporal- or context-related information loss and may distort the actual organization. Therefore, it is necessary to apply multilayer network model to consider multiple types of relationships between diseases and the important interplays between different relationships. Further, modules extracted from multilayer networks are smaller and have more overlap that better capture the actual organization. Here, we constructed a weighted four-layer disease-disease similarity network to characterize the associations at different levels between diseases. Then, a tensor-based computational framework was used to extract Conserved Disease Modules (CDMs) from the four-layer disease network. After filtering, nine significant CDMs were reserved. The statistical significance test proved the significance of the nine CDMs. Comparing with modules got from four single layer networks, CMDs are smaller, better represent the actual relationships, and contain potential disease-disease relationships. KEGG pathways enrichment analysis and literature mining further contributed to confirm that these CDMs are highly reliable. Furthermore, the CDMs can be applied to predict potential drugs for diseases. The molecular docking techniques were used to provide the direct evidence for drugs to treat related disease. Taking Rheumatoid Arthritis (RA) as a case, we found its three potential drugs Carvedilol, Metoprolol, and Ramipril. And many studies have pointed out that Carvedilol and Ramipril have an effect on RA. Overall, the CMDs extracted from multilayer networks provide us with an impressive understanding disease mechanisms from the perspective of multi-layer network and also provide an effective way to predict potential drugs for diseases based on its neighbors in a same CDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.